Last updated on February 2020

A Study of LY2880070 in Participants With Advanced or Metastatic Cancer

Brief description of study

The main purpose of this two-part study is to evaluate the safety and efficacy of the study drug known as LY2880070 in participants with advanced or metastatic solid tumors.

Clinical Study Identifier: NCT02632448

Find a site near you

Start Over